Aceto has terminated William Kennally’s employment as president and CEO of the US company, which remains embroiled in bankruptcy proceedings that have included deals to divest a large chunk of its business.
The company recently completed the sale of its Rising Pharmaceuticals generics unit– along with Rising’s subsidiaries and related assets –...




